Deaths, clinical support and physiology by study visit
| Deaths | Non-invasive ventilation | Invasive ventilation | Supplemental oxygen | SpO2≥94% in air | Spirometry | FVC (% predicted) | FEV1
(% predicted) | |||||
| N | % | N | % | N | % | N | % | N | Median (IQR) | Median (IQR) | ||
| Prior to baseline | 0 | 41/126 | 33 | 43/126 | 34 | 93/125 | 74 | – | – | – | – | – |
| At baseline | 0 | 18/114 | 16 | 16/116 | 14 | 74/117 | 63 | 57/122 | 47 | 25/36 | 48 (34–73) | 50 (35–68) |
| 4 weeks | 10 | 6/80 | 8 | 6/80 | 8 | 37/80 | 46 | 47/83 | 57 | 17/36 | 59 (44–79) | 66 (49–76) |
| 8 weeks | 15 | 2/76 | 3 | 3/75 | 4 | 29/75 | 39 | 52/78 | 67 | 17/36 | 65 (46–83) | 67 (46–81) |
| 12 weeks | 16 | 3/74 | 4 | 2/72 | 3 | 23/74 | 31 | 54/74 | 73 | 18/36 | 77 (57–86) | 74 (56–85) |
| 6 months | 20 | 4/84 | 5 | 2/83 | 3 | 27/83 | 33 | 62/82 | 76 | 21/36 | 75 (61–84) | 70 (59–78) |
| 12 months | 20 | 2/72 | 3 | 1/71 | 1 | 16/69 | 23 | 54/70 | 77 | 18/36 | 80 (69–96) | 74 (65–89) |